MIODRAG ZIVIC: Open Payments
NPI 1225011836 · BEACHWOOD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,052 in 236 payments from 37 companies in 2025. Trend: 2023 $3,139 · 2024 $2,990 · 2025 $4,052
Food & beverage: $4,044Education: $8
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $403 |
| AstraZeneca Pharmaceuticals LP | 11 | $287 |
| Otsuka America Pharmaceutical, Inc. | 11 | $277 |
| PFIZER INC. | 20 | $251 |
| Bayer Healthcare Pharmaceuticals Inc. | 21 | $229 |
| Merck Sharp & Dohme LLC | 10 | $207 |
| GlaxoSmithKline, LLC. | 13 | $199 |
| Amgen Inc. | 18 | $198 |
| Vanda Pharmaceuticals Inc. | 15 | $191 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $144 |
Products named: REXULTI, Kerendia, VERQUVO, TRELEGY ELLIPTA, ELIQUIS, VRAYLAR, FARXIGA, UBRELVY.
Industry payments across OH — which companies pay providers there.
